Workflow
Roscan Gold Announces Closing of Convertible Note Financing
TMX Newsfile· 2026-03-02 22:15
Toronto, Ontario--(Newsfile Corp. - March 2, 2026) - Roscan Gold Corporation (TSXV: ROS) (FSE: 2OJ) (OTCQB: RCGCF) ("Roscan" or the "Company") is pleased to announce that, further to its press release of February 6, 2026, it has completed its non-brokered private placement through the issuance of an aggregate of CAD$1,500,000 principal amount secured subordinate promissory notes (the "Offering"). Gross proceeds of the Offering will be used for general corporate and working capital purposes.The Notes bear i ...
Graco Inc. Announces Appointment of Sanjiv Gupta as Chief Financial Officer and Treasurer; David M. Lowe to Retire After Three Decades of Service
Businesswire· 2026-03-02 22:15
MINNEAPOLIS--(BUSINESS WIRE)--Graco Inc. (NYSE: GGG) announced today that it has appointed Sanjiv Gupta as Chief Financial Officer and Treasurer, effective April 15, 2026. Gupta will succeed David M. Lowe in the role, who recently informed the company of his intention to retire after a more than thirty-year career with Graco. Gupta joins Graco from General Motors Company (NYSE: GM), where he has spent more than twenty years in various finance and operating roles of increasing leadership respons. ...
Linamar and Regen Resources Form Alliance to Advance Battery-Grade Graphite Development in Ontario
Globenewswire· 2026-03-02 22:15
GUELPH, Ontario and WELLAND, Ontario, March 02, 2026 (GLOBE NEWSWIRE) -- Linamar Corporation and Regen Resources today announced a strategic alliance aimed at advancing the commercialization of graphite assets located in Welland, Ontario, supporting the development of a domestic supply of battery-grade graphite for industrial and automotive applications. The alliance brings together Regen’s upstream graphite resource reserve of approximately 340,000 tonnes with Linamar’s downstream processing capability, c ...
Realbotix Provides Financial Reporting Update
Businesswire· 2026-03-02 22:13
Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed IssuerLAS VEGAS--([BUSINESS WIRE])--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) ("Realbotix†or the "Parent Company†), a leader in AI-powered humanoid robots, announces it has entered into a definitive agreement with Onconetix, Inc (NASDAQ: ONCO) ("ONCO†), pursuant to which ONCO will acquire 100% of Realbotix, LLC ("RealLLC†or the "Subsidiary†), a wholly owned subsidiary of Realbotix in an all-stock transaction. RealL ...
TBBB Invites You to Join Its Fourth Quarter & Full Year 2025 Earnings Conference Call
Businesswire· 2026-03-02 22:13
MEXICO CITY--(BUSINESS WIRE)--BBB Foods Inc. (NYSE: TBBB) ("Tiendas 3B†or "the Company†) will report its fourth quarter and full year 2025 earnings on March 11, 2026, after market close. You are invited to join our quarterly conference call, which will be webcast on March 12, 2026, at 12:00 p.m. ET. Anthony Hatoum, Chairman and CEO, and Eduardo Pizzuto, CFO, will host the call and take questions on the results. Event: Tiendas 3B Fourth Quarter and Full Year 2025 Earnings Conference Call When:. ...
Ascendis Pharma A/S (NASDAQ:ASND) Gains Momentum with FDA Approval and Upgraded Rating
Financial Modeling Prep· 2026-03-02 22:11
Core Viewpoint - Ascendis Pharma A/S has received an upgrade from Evercore ISI to "Outperform" with a price target of $324, driven by the FDA's approval of its innovative therapy Yuviwel for achondroplasia in children [1][6]. Group 1: Company Overview - Ascendis Pharma A/S is a biopharmaceutical company focused on developing therapies for rare diseases [1]. - The company's current stock price is approximately $233, with a market capitalization of around $14.3 billion [4]. Group 2: Product Development - The FDA approved Yuviwel, a once-weekly treatment for children with achondroplasia, based on data from three randomized clinical trials [2]. - Yuviwel is the first therapy designed to enhance linear growth in children aged two years and older, marking a significant advancement in treatment options for this rare genetic disorder [2][3]. Group 3: Regulatory Milestones - The approval of Yuviwel under the FDA's Accelerated Approval Program is a major milestone for Ascendis Pharma, emphasizing the therapy's importance [3]. - The company has also received a Rare Pediatric Disease Priority Review Voucher, further highlighting the significance of Yuviwel [3]. Group 4: Market Performance - The stock of ASND has shown fluctuations, with a trading volume of 602,078 shares, indicating strong investor interest [5]. - The stock has a 52-week high of $242 and a low of $124.06, reflecting its volatility in the market [5].
Viper Energy Launches Secondary Common Stock Offering By Diamondback Energy, Inc. and Certain Affiliates of EnCap Investments, L.P. and Oaktree Capital Management, L.P. - Viper Energy (NASDAQ:VNOM)
Benzinga· 2026-03-02 22:11
Viper has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. Copies of the prospectus and prospectus supplement for the Secondary Offering, when available, may be obtained from J.P. Morgan, c/o Broadridge Financial Solutions, 1155 Long Isl ...
Middle East Conflict Lifts Oil; Stocks Rebound From Early Declines
WSJ· 2026-03-02 22:11
A rally in energy and tech stocks helped the S&P 500 rebound from an early 1.2% drop to finish up less than 0.1%. Brent crude moderated an early double-digit surge to a 6.7% climb. ...
Viper Energy Launches Secondary Common Stock Offering By Diamondback Energy, Inc. and Certain Affiliates of EnCap Investments, L.P. and Oaktree Capital Management, L.P.
Globenewswire· 2026-03-02 22:11
MIDLAND, Texas, March 02, 2026 (GLOBE NEWSWIRE) -- Viper Energy, Inc. (NASDAQ: VNOM) (“Viper”) announced today the launch of an underwritten public offering of 17,391,304 shares of its Class A common stock by Diamondback Energy, Inc. and certain affiliates of EnCap Investments, L.P. and Oaktree Capital Management, L.P. (together, the “Selling Stockholders”), subject to market and other conditions (the “Secondary Offering”). Viper will not receive any proceeds from the sale of the shares by the Selling Stock ...
Hercules Capital, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Globenewswire· 2026-03-02 22:11
SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Hercules Capital, Inc. (NYSE: HTGC). The investigation focuses on Hercules’ executive officers and whether investor losses may be recovered under federal securities laws. What if I purchased Hercules securities? If you purchased Hercules securities and suffered losses on your investment, join our investigation now: Click here to join the investigation. Or for more information, conta ...